These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute neurobehavioral effects in rats from exposure to HFC 134a or CFC 12. Ritchie GD, Kimmel EC, Bowen LE, Reboulet JE, Rossi J. Neurotoxicology; 2001 Apr; 22(2):233-48. PubMed ID: 11405255 [Abstract] [Full Text] [Related]
5. Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure. Gunnare S, Ernstgård L, Sjögren B, Johanson G. Toxicol Lett; 2006 Nov 01; 167(1):54-65. PubMed ID: 17030466 [Abstract] [Full Text] [Related]
6. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ramsdell JW, Colice GL, Ekholm BP, Klinger NM. Ann Allergy Asthma Immunol; 1998 Dec 01; 81(6):593-9. PubMed ID: 9892032 [Abstract] [Full Text] [Related]
7. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group. Salat D, Popov D, Sykes AP. Respir Med; 2000 Jun 01; 94 Suppl B():S22-8. PubMed ID: 10919682 [Abstract] [Full Text] [Related]
8. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J. Eur J Clin Pharmacol; 1995 Jun 01; 48(6):473-7. PubMed ID: 8582466 [Abstract] [Full Text] [Related]
10. Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects. Harrison LI, Donnell D, Simmons JL, Ekholm BP, Cooper KM, Wyld PJ. J Pharm Pharmacol; 1996 Jun 01; 48(6):596-600. PubMed ID: 8832493 [Abstract] [Full Text] [Related]
11. Defluorination of the CFC-substitute 1,1,1,2-tetrafluoroethane: comparison in human, rat and rabbit hepatic microsomes. Olson MJ, Surbrook SE. Toxicol Lett; 1991 Dec 01; 59(1-3):89-99. PubMed ID: 1755039 [Abstract] [Full Text] [Related]
12. 1,1,2,2-Tetrafluoroethane (HFC-134) (2018). Toxicol Ind Health; 2019 Mar 01; 35(3):196-203. PubMed ID: 30862299 [Abstract] [Full Text] [Related]
14. The CFC to HFA transition and its impact on pulmonary drug development. Leach CL. Respir Care; 2005 Sep 01; 50(9):1201-8. PubMed ID: 16122403 [Abstract] [Full Text] [Related]
18. Atmospheric Observation and Emission of HFC-134a in China and Its Four Cities. Yi L, Xiang X, Zhao X, Xu W, Jiang P, Hu J. Environ Sci Technol; 2023 Mar 28; 57(12):4732-4740. PubMed ID: 36917702 [Abstract] [Full Text] [Related]
19. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients. Molimard M, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G. Respiration; 2005 Mar 28; 72 Suppl 1():28-34. PubMed ID: 15915010 [Abstract] [Full Text] [Related]
20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D. Toxic Rep Ser; 1995 Apr 28; 30():1-G5. PubMed ID: 12209194 [Abstract] [Full Text] [Related] Page: [Next] [New Search]